BioSpace News Archive

Business

Poxel to Report Financial Results for Full Year 2021 and Host Webcast Call on March 22, 2022

POXEL SA announced that it will report its financial results for the Full Year 2021 on Tuesday, March 22, 2022.

March 15, 2022
·
2 min read
Meningitis Imaging Market to Offer the Most Reliable Test for Detecting Bacterial and Viral Meningitis

Acute bacterial meningitis is a common, severe, neurological illness that may lead to death or neurological disabilities.

March 15, 2022
·
3 min read
Stem Cell Umbilical Cord Blood Market to Gain Importance in Asia-Pacific Region

Stem cell-based therapies have increasingly become popular and are being accepted as a promising treatment for chronic disorders.

March 15, 2022
·
3 min read
Kamada Issues 2022 CEO Letter to Shareholders

Kamada Ltd., a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, issued the Letter to Shareholders from Amir London, Chief Executive Officer.

March 15, 2022
·
11 min read
Business

ASLAN Pharmaceuticals Appoints Dermatology Veteran Dr Alex Kaoukhov as Chief Medical Officer

ASLAN Pharmaceuticals announced the appointment of Alex Kaoukhov, MD, as Chief Medical Officer based in ASLAN’s US office, effective immediately.

March 15, 2022
·
3 min read
Business

ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES EXECUTIVE LEADERSHIP CHANGES

Ortho Regenerative Technologies Inc. today announced the appointment of Philippe Deschamps as its new Chief Executive Officer following the retirement of Mr. LeDuc, the Company’s CEO for the last three years.

March 15, 2022
·
5 min read
BioMidwest

New Alzheimer’s Association Report Finds Doctors and the Public Face Challenges in Understanding and Distinguishing Early Alzheimer’s Development from ‘Normal Aging’

The Alzheimer’s Association 2022 Alzheimer’s Disease Facts and Figures report unearthed new insights related to challenges both doctors and the American public face in understanding and diagnosing mild cognitive impairment (MCI).

March 15, 2022
·
11 min read
Biotech Bay

JSR Life Sciences’ Amsphere A3 Integrated into the Commercial Manufacturing of FDA-Approved Antibody Therapy

JSR Life Sciences, LLC today announced that its lead product, Amsphere™ A3, has been incorporated for the first time into the commercial manufacturing of an FDA-approved treatment.

March 15, 2022
·
2 min read
Business

Epizyme Announces Executive Appointment and Provides Tazemetostat Clinical Update

Epizyme Announces Executive Appointment and Provides Tazemetostat Clinical Update.

March 15, 2022
·
7 min read
Business

Acerus Reports Fourth Quarter and Full Year 2021 Financial Results

Acerus Pharmaceuticals Corporation reported its financial results for the three and twelve-month period ended December 31, 2021.

March 15, 2022
·
14 min read